CME Noncontrolling Interest In Consolidated Entity History

CME Stock  USD 287.27  2.74  0.96%   
Noncontrolling Interest in Consolidated Entity stood at 36.3 M as of December 31, 2025. Over the last 16 observed reporting periods, Noncontrolling Interest in Consolidated Entity has increased at a moderate pace, with partial explanatory fit (R² 0.69) in the linear model. View All Financial Accounts
 
Noncontrolling Interest In Consolidated Entity  
 First Reported
2009-09-30
 Previous Quarter
28 M
 Current Value
24.2 M
 Quarterly Volatility
13.2 M
Macro event markers
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Latest CME Noncontrolling Interest In Consolidated Entity Growth Pattern

Noncontrolling Interest In Consolidated Entity10 Years Trend
Moderate Growth
   Noncontrolling Interest In Consolidated Entity   
       Timeline  

Noncontrolling Interest In Consolidated Entity Trend Statistics

Measured across 6 periods, CME's Noncontrolling Interest In Consolidated Entity has a coefficient of variation of 95.9% (wide dispersion driven primarily by directional growth rather than instability). The regression fit of 0.69 reflects a strong linear fit indicating consistent directional movement.
Arithmetic Mean 18,552,765
Geometric Mean0.00
Coefficient Of Variation 95.90
Mean Deviation 16,790,837
Median 30,400,000
Standard Deviation 17,791,775
Sample Variance316.5T
Range46.8M
R-Value 0.83
Mean Square Error104.9T
R-Squared 0.69
Significance 0.000037
Slope 2,925,333
Total Sum of Squares5064.8T

CME Noncontrolling Interest In Consolidated Entity History

Reported values for CME's Noncontrolling Interest In Consolidated Entity span 2013 to 2026 (6 observations), ranging from 5.7 M to 38.2 M.
202638.2 M
202536.3 M
202031.6 M
201930.4 M
201846.8 M
20135.7 M

Correlation of Noncontrolling Interest In Consolidated Entity With Other Accounts

The table presents linear correlations between CME's Noncontrolling Interest In Consolidated Entity and adjacent financial accounts. Positive values indicate co-directional movement; negative values indicate inverse movement. These relationships describe association, not causation.

Related Fundamentals

Last ReportedEnd Of Year Estimate
Price To Sales Ratio 15.06 8.36
Dividend Yield4.00%2.45%
PTB Ratio 3.42 3.78
Days Sales Outstanding 35.78 43.66
Book Value Per Share 79.88 40.43

Methodology, Assumptions & Data Sources

A longitudinal view of CME's Noncontrolling Interest In Consolidated Entity is provided for trend analysis. Benchmarking this metric against sector peers distinguishes company-specific movement from industry-wide patterns. As a Financial Exchanges & Data company, CME's Noncontrolling Interest In Consolidated Entity should be benchmarked against sector peers for meaningful interpretation.

CME Group inputs come from periodic company reporting and market reference feeds and are mapped into a consistent reporting framework. Reference data and historical patterns are presented and do not constitute an investment recommendation or advice.

Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board